Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.7 USD | -8.38% | -7.96% | -49.79% |
06:04pm | Stifel Adjusts Price Target on ACADIA Pharmaceuticals to $21 From $26, Keeps Hold Rating | MT |
May. 08 | Transcript : ACADIA Pharmaceuticals Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.79% | 2.83B | |
+24.79% | 46.71B | |
+48.83% | 41.8B | |
-1.09% | 41.52B | |
-5.86% | 29.55B | |
+10.91% | 25.78B | |
-20.51% | 19.26B | |
+2.45% | 12.14B | |
-3.40% | 12.08B | |
+28.91% | 11.98B |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- Transcript : ACADIA Pharmaceuticals Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 11